Staphylococcal Scalded Skin Syndrome

SSSS Introduction - Scaly Skin Saga

• A superficial blistering skin condition caused by specific Staphylococcus aureus strains.
• Primarily affects neonates, infants, and young children (typically <5 years).
• Pathogenesis: Mediated by exfoliative toxins (ETA and ETB).
  • These toxins specifically cleave desmoglein-1.
  • Site of cleavage: Stratum granulosum of the epidermis.
• Leads to widespread erythema, bullae formation, and subsequent desquamation.
• Nikolsky sign is characteristically positive.

⭐ Exfoliative toxins (ETA, ETB) from Staphylococcus aureus cleave desmoglein-1 in the stratum granulosum.

Clinical Features - Red, Raw, Peeling

• Initial Phase: Prodrome of fever, irritability, and diffuse skin tenderness.
• Erythema & Bullae Formation:
  • Widespread, tender erythema appears; often starts periorificially (mouth, eyes), neck, axillae, and groin.
  • Within 24-48 hours, large, flaccid, sterile bullae develop.
  • Bullae rupture easily, revealing moist, red, raw "scalded" skin surface.
• Characteristic Signs:
  • Exquisite pain and tenderness on palpation.
  • Mucous membranes are typically spared (important diagnostic clue).

  ⭐ Nikolsky's sign (gentle rubbing causes exfoliation of the outermost skin layer) is typically positive in SSSS.

• Distribution: Primarily affects flexural areas, trunk, and periorificial regions; palms and soles usually spared.
• Resolution: Rapid healing within 7-10 days if treated, typically without scarring.

Diagnosis & Differentials - Spotting the Scald

• Clinical Dx: Sudden onset erythroderma, fever, skin tenderness, positive Nikolsky sign.
• Skin Biopsy (Gold Standard):
  • Intraepidermal split at stratum granulosum.
  • Minimal/no inflammatory cells in blister.

  ⭐ Skin biopsy in SSSS shows an intraepidermal split at the stratum granulosum level, with minimal or no inflammatory cells in the blister cavity, distinguishing it from TEN.

• Cultures:
  • Source: Blood, nasopharynx, suspected primary site (NOT intact blister).
  • Blister fluid: Usually sterile.
• Key Differentials:
  • Toxic Epidermal Necrolysis (TEN): Deeper split (dermo-epidermal), severe mucosal involvement, drug hx.
  • Bullous Impetigo: Localized, culture-positive blisters.
  • Kawasaki Disease: No Nikolsky, coronary concerns.

Management & Prognosis - Soothe & Subdue

• Core Management (Hospitalize):
  • Supportive: Crucial. IV fluids, electrolyte balance, temperature control, meticulous skin care (emollients, non-adherent dressings to minimize trauma), analgesia.
  • Antibiotics: IV anti-staphylococcal (Nafcillin, Oxacillin, Flucloxacillin). Add Clindamycin (inhibits toxin). Vancomycin if MRSA suspected/confirmed.
• Prognosis:
  • Children: Generally excellent. Full recovery typically within 7-14 days, usually without scarring.
  • Adults & Immunocompromised: Higher morbidity/mortality.

⭐ Corticosteroids are contraindicated in SSSS as they can impair immune response and worsen the condition.

High‑Yield Points - ⚡ Biggest Takeaways

• Caused by Staphylococcal exfoliative toxins (ETA, ETB) targeting desmoglein-1.
• Leads to intraepidermal split at stratum granulosum; Nikolsky sign positive.
• Presents as tender erythroderma, widespread bullae, and desquamation, mainly in children <5 years.
• Mucous membranes are characteristically spared, distinguishing it from TEN/SJS.
• Bullae are sterile as it's toxin-mediated; biopsy shows subcorneal split.
• Treat with systemic anti-staphylococcal antibiotics and supportive measures.